Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. Jennifer Henderson’s road to recovery from long COVID has been […]
TOPLINE: For advanced cancers other than melanoma, adding ipilimumab to nivolumab does not improve survival over nivolumab alone, but it does increase clinical and financial toxicity. […]
TOPLINE: Dupilumab provides histologic, endoscopic, and symptomatic improvement in patients with severe, treatment-refractory, fibrostenotic eosinophilic esophagitis (EoE), new research shows. METHODOLOGY: Researchers conducted a retrospective cohort […]
The frequency of medication errors among children who take drugs to treat attention-deficit/hyperactivity disorder (ADHD) reported to US poison control centers increased by nearly 300% over […]
TOPLINE: Patients with type 1 diabetes who received transplanted islets along with a kidney transplant had significantly reduced mortality and transplant failure risks compared with those […]
The US Food and Drug Administration (FDA) today approved the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis patients with anemia, according to a press release from maker […]
The first randomized trial to evaluate postprocedural anticoagulation (PPA) in patients undergoing a primary percutaneous coronary intervention (PCI) for an ST-segment elevation myocardial infarction (STEMI) did […]
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization of lebrikizumab for the treatment of adult and […]
Lecanemab (Lequembi, Esai), an amyloid beta–directed antibody therapy, is approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease (AD). But […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.